Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News DaVita Inc DVA

Healthcare
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers... see more

Recent & Breaking News (NYSE:DVA)

DaVita Announces Adam H. Schechter to Join its Board of Directors

PR Newswire September 13, 2022

Federman & Sherwood Investigates DaVita, Inc. for Data Breach

Business Wire September 12, 2022

DaVita Inc. 2nd Quarter 2022 Results

PR Newswire August 1, 2022

American Diabetes Association Focuses on Prevention of Kidney Disease through Collaboration with DaVita

PR Newswire July 25, 2022

DaVita Inc. Schedules 2nd Quarter 2022 Investor Conference Call

PR Newswire July 18, 2022

Rockwell Medical Provides Corporate and Clinical Update

PR Newswire June 22, 2022

DaVita Inc. Schedules Special Investor Conference Call

PR Newswire June 22, 2022

Medtronic and DaVita announce new kidney health technology company

PR Newswire May 26, 2022

DaVita Honors Extraordinary Nurses with DAISY Awards

PR Newswire May 10, 2022

DaVita Inc. to Participate in the Bank of America Securities 2022 Healthcare Conference

PR Newswire May 9, 2022

DaVita Inc. 1st Quarter 2022 Results

PR Newswire May 5, 2022

DaVita Celebrates 2021 ESG, Corporate Social Responsibility Achievements

PR Newswire May 3, 2022

DaVita Inc. Schedules 1st Quarter 2022 Investor Conference Call

PR Newswire April 21, 2022

Rockwell Medical Expands Partnership with DaVita

PR Newswire April 11, 2022

DaVita Announces Jason M. Hollar to Join its Board of Directors

PR Newswire April 7, 2022

New Research Affirms Increase in Access, Equity of COVID-19 Vaccines Administered in Dialysis Centers

PR Newswire April 4, 2022

Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease

PR Newswire March 1, 2022

DaVita Clinical Research Study Finds Efficacy of Common COVID-19 Vaccines at Parity for Kidney Patients

PR Newswire February 17, 2022

DaVita Kidney Care Appoints New Chief Medical Officer of Home Modalities

PR Newswire February 16, 2022

DaVita expands paid leave to support teammates choosing to be living organ donors

PR Newswire February 14, 2022